eXoZymes (EXOZ) Proxy Filing summary

Executive summary

• Annual meeting scheduled for July 25, 2025, at 1:00 PM PST, to be held virtually.

• Proxy materials, including the 10K and proxy statement, are available online for shareholder review.

• Proxies Michael Heltzen and Fouad Nawaz authorized to vote shares as directed by shareholders.

Voting matters and shareholder proposals

• Shareholders will vote to elect six director nominees to serve until the 2026 annual meeting.

• Proposal to approve the 2025 Performance Equity Plan is on the ballot.

• Ratification of RBSM LLP as independent registered public accounting firm for fiscal year ending December 31, 2025.

• Advisory vote on executive compensation ("say-on-pay") for the 2025 fiscal year.

• Advisory vote on the frequency of future say-on-pay votes, with options for 1, 2, or 3 years.

Board of directors and corporate governance

• Proxy card corrected to allow shareholders to withhold votes for individual director nominees.

• Six nominees listed: Christopher Marlett, Anthony DiGiandomenico, Edgardo Rayo, James Lalonde, James Bowie, and Lon Bell.

• Board recommends voting FOR all director nominees and key proposals.